Trial record 1 of 1 for:    0761-010
Previous Study | Return to List | Next Study

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Kyowa Hakko Kirin Pharma, Inc.
Sponsor:
Information provided by (Responsible Party):
Kyowa Hakko Kirin Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT01728805
First received: October 25, 2012
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)